A Practical Guide to Immunoassay Method ValidationUlf Andréasson, Charlotte E. Teunissen, Armand Perret‐Liaudet et al.|Frontiers in Neurology|2015Cited by 541
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute strokeCamilla Hesse, Kaj Blennow, Lars Rosengren et al.|Neuroscience Letters|2001Cited by 452
Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP TechnologyAnnika Olsson, Kaj Blennow, Hugo Vanderstichele et al.|Clinical Chemistry|2004Cited by 441
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detectedMarc Suárez‐Calvet, Natàlia Vilor‐Tejedor, Gemma Salvadó et al.|EMBO Molecular Medicine|2020Cited by 411
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s diseaseMarta Milà‐Alomà, Kaj Blennow, Nicholas J. Ashton et al.|Nature Medicine|2022Cited by 349